优化投资控股体系
Search documents
葵花药业集团股份有限公司关于注销全资子公司的进展公告
Shang Hai Zheng Quan Bao· 2025-11-25 19:02
Group 1 - The company has decided to deregister its wholly-owned subsidiary Heilongjiang Kuihua Pharmacy Co., Ltd. to optimize its investment holding system and reduce management layers [2][3] - The decision aims to achieve effective resource integration and cost reduction for concentrated development [2] - The deregistration process has been completed, and the company has received the deregistration notice from the Market Supervision Administration of Wuchang City [3] Group 2 - The deregistration of the subsidiary will not have a significant impact on the overall financial and operational situation of the company [3] - There are no adverse effects on the rights and interests of the company and all shareholders, particularly minority shareholders [3]